Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the ...

A new study highlighted Monday the potential benefits of popular diabetes drugs on a wide range of health issues including dementia and cardiovascular diseases, although experts warned against seeing ...

Novo Nordisk has faced a massive selloff in recent months amid disappointing drug trials and U.S. pressure to cut its prices.

alleging that the companies manipulated the prices of insulin and other diabetes medications. The FCPS lawsuit alleges that pharmaceutical companies Eli Lilly, Sanofi, and Novo Nordisk and ...

When he announced the Civica deal in early 2023, Newsom made it clear that the ... The three major brand-name insulin manufacturers — Eli Lilly, Novo Nordisk and Sanofi — cut prices between ...

The use of weight-loss jabs may be associated with wider health benefits including lower risk of stroke and dementia, a study ...